Filing Details
- Accession Number:
- 0001213900-22-037231
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-05 16:30:38
- Reporting Period:
- 2022-06-30
- Accepted Time:
- 2022-07-05 16:30:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1553643 | Relmada Therapeutics Inc. | RLMD | Pharmaceutical Preparations (2834) | 455401931 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1565832 | Sergio Traversa | C/O Relmada Therapeutics, Inc. 2222 Ponce De Leon Blvd, 3Rd Floor Coral Gables, FL 33134 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-30 | 16,012 | $16.00 | 104,786 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-06-30 | 5,314 | $19.37 | 99,472 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-06-30 | 10,698 | $19.01 | 88,774 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-07-01 | 13,755 | $16.00 | 102,529 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-07-01 | 839 | $18.48 | 101,690 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-07-01 | 8,848 | $18.45 | 92,842 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-07-01 | 4,068 | $18.32 | 88,774 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2022-06-30 | 16,012 | $0.00 | 16,012 | $16.00 |
| Common Stock | Stock Option (right to buy) | Disposition | 2022-07-01 | 13,755 | $0.00 | 13,755 | $16.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,755 | 2012-07-10 | 2022-07-10 | No | 4 | M | Direct |
| 0 | 2012-07-10 | 2022-07-10 | No | 4 | M | Direct |
Footnotes
- The transaction reported on this Form 4 reflects the exercise of stock options set to expire on July 10, 2022.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- Sales prices range from $19.20 to $19.51 per share, inclusive.
- Sales prices range from $19.00 to $19.15 per share, inclusive.
- Sales prices range from $18.47 to $18.53 per share, inclusive.
- Sales prices range from $18.45 to $18.47 per share, inclusive.
- Sales prices range from $18.26 to $18.44 per share, inclusive.
- The options were granted on July 10, 2012 (the "Grant Date"). 25% of the options vested upon the Grant Date and the remaining 75% of the options vested in equal quarterly increments over the next four (4) years, so that the last set of options vested in July 2016.
Billionaire Hedge Funds
